These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15564639)

  • 1. Delayed multiple injection site reaction in a rheumatoid arthritis patient treated with etanercept.
    Rajakulendran S; Deighton C
    Rheumatology (Oxford); 2004 Dec; 43(12):1588-9. PubMed ID: 15564639
    [No Abstract]   [Full Text] [Related]  

  • 2. Etanercept-induced dermatitis in a patient with rheumatoid arthritis.
    Lai-Cheong J; Warren R; Bucknall R; Parslew R
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):614-5. PubMed ID: 16684300
    [No Abstract]   [Full Text] [Related]  

  • 3. Recall injection-site reactions associated with etanercept therapy: report of two new cases with immunohistochemical analysis.
    González-López MA; Martínez-Taboada VM; González-Vela MC; Blanco R; Fernández-Llaca H; Rodríguez-Valverde V; Val-Bernal JF
    Clin Exp Dermatol; 2007 Nov; 32(6):672-4. PubMed ID: 17953638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasiform and pustular eruption induced by etanercept and infliximab.
    Kuhara T; Watanabe D; Iwahori Y; Tamada Y; Yamamura M; Matsumoto Y
    Eur J Dermatol; 2009; 19(4):388-9. PubMed ID: 19467963
    [No Abstract]   [Full Text] [Related]  

  • 5. Psoriasis after treatment of juvenile idiopathic arthritis with etanercept.
    Peek R; Scott-Jupp R; Strike H; Clinch J; Ramanan AV
    Ann Rheum Dis; 2006 Sep; 65(9):1259. PubMed ID: 16905590
    [No Abstract]   [Full Text] [Related]  

  • 6. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Martínez-Taboada VM; Val-Bernal JF; Pesquera LC; Fernández-Llanio NE; Esteban JM; Blanco R; Alonso-Bartolome P; Gonzalez-Vela C; Rodríguez-Valverde V
    Scand J Rheumatol; 2006; 35(4):322-3. PubMed ID: 16882599
    [No Abstract]   [Full Text] [Related]  

  • 7. Interstitial granulomatous dermatitis in a patient with rheumatoid arthritis on etanercept.
    Levine SD; Robinson M; Honda K; Nedorost S
    Cutis; 2009 Jan; 83(1):50. PubMed ID: 19271571
    [No Abstract]   [Full Text] [Related]  

  • 8. Diffuse skin reaction after changing the etanercept formulation.
    Caporali R; Bobbio-Pallavicini F; Caprioli M; Scorletti E; Montecucco C
    Clin Exp Rheumatol; 2008; 26(6):1165. PubMed ID: 19210894
    [No Abstract]   [Full Text] [Related]  

  • 9. Angio-oedema in a patient treated with etanercept for rheumatoid arthritis.
    Sendur OF; Turan Y; Berkit IK; Tastaban E
    Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):488-90. PubMed ID: 19371261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary rheumatoid nodules in an etanercept-treated patient.
    Hübscher O; Re R; Iotti R
    Arthritis Rheum; 2003 Jul; 48(7):2077-8. PubMed ID: 12847707
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukocytoclastic vasculitis due to etanercept.
    Galaria NA; Werth VP; Schumacher HR
    J Rheumatol; 2000 Aug; 27(8):2041-4. PubMed ID: 10955351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic cellulitislike reaction to subcutaneous etanercept injection.
    Winfield H; Lain E; Horn T; Hoskyn J
    Arch Dermatol; 2006 Feb; 142(2):218-20. PubMed ID: 16490850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept-associated pulmonary granulomatous inflammation in patients with rheumatoid arthritis.
    Ognenovski VM; Ojo TC; Fox DA
    J Rheumatol; 2008 Nov; 35(11):2279-82. PubMed ID: 19004058
    [No Abstract]   [Full Text] [Related]  

  • 14. Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis.
    Carlson E; Rothfield N
    Arthritis Rheum; 2003 Apr; 48(4):1165-6; author reply 1166. PubMed ID: 12687569
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein.
    Zeltser R; Valle L; Tanck C; Holyst MM; Ritchlin C; Gaspari AA
    Arch Dermatol; 2001 Jul; 137(7):893-9. PubMed ID: 11453808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis.
    Watson P; Simler N; Screaton N; Lillicrap M
    Rheumatology (Oxford); 2008 Jun; 47(6):928-9. PubMed ID: 18385217
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanercept.
    Uthman I; Husari A; Touma Z; Kanj SS
    Rheumatology (Oxford); 2005 Sep; 44(9):1200-1. PubMed ID: 15870144
    [No Abstract]   [Full Text] [Related]  

  • 18. Henoch-Schönlein purpura in a patient with rheumatoid arthritis receiving etanercept.
    Asahina A; Ohshima N; Nakayama H; Shirai A; Juji T; Matsui T
    Eur J Dermatol; 2010; 20(4):521-2. PubMed ID: 20413370
    [No Abstract]   [Full Text] [Related]  

  • 19. Occurrence of cold agglutinin disease in RA patient during etanercept therapy successfully treated with rituximab.
    Malesci D; La Montagna G
    Rheumatology (Oxford); 2008 May; 47(5):734-5. PubMed ID: 18326535
    [No Abstract]   [Full Text] [Related]  

  • 20. Dermatological complications of etanercept therapy for rheumatoid arthritis.
    Misery L; Perrot JL; Gentil-Perret A; Pallot-Prades B; Cambazard F; Alexandre C
    Br J Dermatol; 2002 Feb; 146(2):334-5. PubMed ID: 11903255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.